A pivotal phase 3 clinical trial to assess the diagnostic performance and safety of [68Ga]Ga-PentixaFor ([68Ga]Ga-PTF), a positron emission tomography (PET) imaging agent, versus [18F]FDG PET/CT imaging, for staging of patients with confirmed marginal zone lymphoma (MZL) exemplary for CXCR4-positive malignant lymphomas: a prospective, international, multi-center, comparative, randomized, cross-over, open-label lymphoma diagnostic trial (LYMFOR).
This study is looking at people who have been diagnosed with marginal zone lymphoma, which is a type of cancer. It compares two different types of body scans, called PET/CT scans. One scan uses a substance called [68Ga]Ga-PentixaFor, and the other uses [18F]FDG. The main goal is to find out if the [68Ga]Ga-PentixaFor scan is better, or at least as good as, the standard [18F]FDG scan at spotting cancer cells in the body. Researchers also want to see if these scans help doctors plan the best treatment for patients and how different doctors interpret the scan results. This information will help improve how this cancer is diagnosed and managed.
Em resumo
Sobre o que é este estudo?
This study is about a type of cancer called marginal zone lymphoma. When someone is diagnosed with cancer, doctors need to know if the cancer has spread and how much. This process is called "staging," and it helps doctors decide on the best treatment plan. Currently, a type of scan called an [18F]FDG PET/CT scan is often used for this purpose.
This study is comparing that standard [18F]FDG PET/CT scan with a newer type of scan called a [68Ga]Ga-PentixaFor PET/CT scan. Both are types of body scans that can help doctors see inside the body. The researchers want to find out if the newer [68Ga]Ga-PentixaFor scan is better or at least as good as the standard scan at finding cancer cells. They are particularly interested in seeing if it can find cancer cells more accurately.
The study will also look at how reliable each scan is, meaning whether different doctors get the same results when looking at the scans. Importantly, they want to see if the information from either scan changes how doctors decide to treat a patient. By comparing these two scans, the study hopes to improve the way marginal zone lymphoma is diagnosed and to help doctors make more informed decisions about treatment.
Pontos principais
- A study for people with marginal zone lymphoma.
- Compares two types of body scans (PET/CT) to find cancer more effectively.
- Aims to see if a newer scan is better than the standard one.
- Hopes to improve how marginal zone lymphoma is diagnosed and managed.
- Participation involves having two different diagnostic scans and follow-up.
Quem pode ser elegível?
To be considered for this study, you must be at least 18 years old. Both men and women can take part.
Key to joining is having a confirmed diagnosis of marginal zone lymphoma. This means your doctors have already found that you have this specific type of cancer.
The study welcomes people of all ages who meet the basic requirements, but there will be specific medical checks to ensure it's safe for you to participate.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Você tem 18 anos ou mais?
- Have you been diagnosed with marginal zone lymphoma?
- Are you able to travel to the study site for appointments?
- Are you comfortable having two different types of body scans?
O que envolve a participação?
If you join this study, you will have two different types of PET/CT body scans. These scans will be done at different times, in no particular order. You will also have follow-up appointments where doctors will check your progress and review your medical information and scan results. The exact number of visits and the total length of your participation will be explained in detail by the study team, but it includes the scans and ongoing monitoring of your condition.
Riscos e benefícios potenciais
Localizações (5)
- —Não verificadoAlemanha
- —Não verificadoItália
- —Não verificadoEspanha
- —Não verificadoFrança
- —Não verificadoÁustria
Perguntas frequentes
What is marginal zone lymphoma?
Marginal zone lymphoma is a type of cancer that affects a certain kind of white blood cell called lymphocytes. It's generally a slow-growing cancer.
What is a PET/CT scan?
A PET/CT scan is a special imaging test that combines two types of scans. It helps doctors see how well your body's cells are working and can pinpoint areas of disease, like cancer.
What's the difference between the two scans being compared?
Both are PET/CT scans, but they use slightly different substances (called 'tracers') to highlight areas in your body. The study wants to see if one tracer is better at finding marginal zone lymphoma cells than the other.
Will my treatment change if I join the study?
The study aims to see if these scans *impact* treatment planning, but your actual treatment decisions will always be made by your doctor based on all available information, including your study results.
Eu tenho que pagar para participar do estudo?
No, you do not have to pay to participate in a clinical trial. All study-related procedures and scans will be covered.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Interessado em participar?
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.